Pharming PHAR
NASDAQ PHAR
$10.55 +0.90 (+9.33%)
As of: Oct 22, 2026 · 10:55 AM EDT

Pharming (PHAR) Times Interest Earned (2020 - 2021)

Updated

Pharming's Times Interest Earned came in at -2.79 for Q4 2021, compared with 4.44 a year earlier.

Analysis

Pharming (PHAR) Times Interest Earned (2020 - 2021) Analysis & Trends

For FY2021, Pharming's Times Interest Earned was 1.54.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn -
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn 25.41
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn -
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn -
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn 10.28
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn 7.27
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn -42.08
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn -
10 Pharming 726.66 Mn -67.71 Mn 141.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 2.92
Mar 31, 2021 0.95
Dec 31, 2020 1.43
API Access

Pharming Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=PHAR&period=max&api_key=YOUR_API_KEY